Scott C. Neils - Jan 3, 2022 Form 3 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role: Interim CFO
Signature: /s/ Amy E. Culbert, attorney-in-fact
Stock symbol: XTNT
Transactions as of: Jan 3, 2022
Transactions value $: $0
Form type: 3
Date filed: 1/10/2022, 03:15 PM
Next filing: Jan 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	XTNT	Common Stock, $0.000001 par value						78.1K	Jan 3, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	XTNT	Employee Stock Option (right to buy)							Jan 3, 2022	Common Stock	96.2K	$1.27	Direct	F2
holding	XTNT	Employee Stock Option (right to buy)							Jan 3, 2022	Common Stock	20.5K	$1.80	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 78,125 shares that will be issued over time subject to vesting pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
F2	This option vests with respect to 24,038 shares on August 15, 2022 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.
F3	This option vested with respect to 5,127 shares on each of November 15, 2020 and November 15, 2021 and will vest with respect to 5,127 shares on each of November 15, 2022 and November 15, 2023, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.